Talent Risk

Talent Risk · Employers · Pharma & healthcare

GSK

(formerly GlaxoSmithKline), the UK pharmaceutical companyPharma & healthcareHQ UK≈68,000 staff

SignsReported, not yet confirmed: one major outlet · since 15th November 2026 · was Cutting last week
Updated 21st November 202626 weeks
1,217
Jobs in announced cuts · 90 days and 12 months
1.8%
Of its staff · 12 months
14th Oct 2026
Latest on record

GSK is showing signs of job cuts.

Reported, not yet confirmed: one major outlet. Latest, on 14th October: GSK announced potential cuts of up to 1,217 jobs in Belgium as part of a three-year restructuring plan to save £1.9 billion.

For scale: at the UK redundancy rate (4.0 per 1,000 employees in June to August 2026, ONS), an employer of 68,000 people would see about 1,100 redundancies a year. This record counts only cuts announced publicly or filed as a formal notice. ONS

How to read this page
  • The label (Cutting, Signs or Quiet) comes from one published rule applied to the sources listed: the company, formal notices and named outlets. The rule
  • The figures count each announcement once. Where a figure is left out, the record says why (one report only, offered not cut, same round).
  • Summary says what is happening and what would change the label; Full record lists every report, linked.

What’s happening, and where

  1. 14th Oct 2026

    GSK to cut 1,217 jobs

    GSK announced potential cuts of up to 1,217 jobs in Belgium as part of a three-year restructuring plan to save £1.9 billion.

    BelgiumOne major outlet so far: Reuters · 3 sources in allEvery source →

    1,217 jobsCounted
  2. 11th Sep 2026

    GSK to cut 641 jobs

    GSK announced closure of its vaccine factory in Germany, putting 641 jobs at risk.

    GermanyOne major outlet so far: Reuters · 2 sources in allEvery source →

    641 jobsFigure given by one report only

Which jobs Factory and production · Research and development

Why, as stated Cutting costs · Restructuring or new strategy · Closing sites or units

Next This becomes Cutting if the company, a formal notice or a second major outlet confirms cuts.

The last 12 months

DecJanFebMarAprMayJunJulAugSeptOctNov14th Oct 2026: GSK announced potential cuts of up to 1,217 jobs in Belgium as part of a three-year restructuring plan to save £1.9 billion.11th Sep 2026: GSK announced closure of its vaccine factory in Germany, putting 641 jobs at risk.19th Aug 2026: GSK announced job cuts as part of a £1.9bn cost-cutting programme to fund a £400m UK life sciences investment, including a new Cambridge R&D centre. The company will close its Stevenage R&D site by 2029 and move over 1,000 scientists to Cambridge.28th Jul 2026: GSK announced a $2.5 billion restructuring programme to accelerate new drug development and raise margin outlook.28th Jul 2026: GSK announced closure of its historic Stevenage research site with relocation of research centre to Cambridge.9th Jan 2026: GSK cut 400 jobs in Belgium during 2025.1.2k641400
CutsBuyouts, plans and signsHiringBigger mark = more jobs named

Out of the ordinary. 1.8% of its workforce in 90 days — nothing comparable recorded in the previous nine months.

This label is our opinion, reached by applying one published rule to the sources listed. GSK can correct the record at any time.

At a glance

LabelSigns since the week to 21st Nov
Jobs in announced cuts, 90 days and 12 months1,217 · 1.8% of about 68,000 staff
Latest on the record14th October 2026 · Cuts announced · 1,217 jobs
Jobs named in cutsFactory and production · Research and development
Hiring or redeploying intoResearch and development
Where the jobs areStevenage · Ware · Cambridge · Wavre · Belgium, Germany, UK
Why, as statedCutting costs · Restructuring or new strategy · Closing sites or units
Jobs we count1,217 of the 2,258 jobs reported, each round once; not counted: 1,041 in 2 figures: figure given by one report only. How we count
Normal for them?Out of the ordinary. 1.8% of its workforce in 90 days — nothing comparable recorded in the previous nine months.
Sources, 12 months20 reports from 11 outlets, each linked below
Headquarters · sectorUK · Pharma & healthcare · GSK
Which companyGSK plc (formerly GlaxoSmithKline), the UK pharmaceutical company. Not Haleon.

Identifiers Wikidata Q212322 · LEI 5493000HZTVUYLO1D793 · SEC CIK 0001131399 · Companies House 03888792 · ISIN GB0009252882 · GSK on London Stock Exchange · GSK on New York Stock Exchange · About these

Filings under 77 other names count for GSK

A formal notice counts here when it is filed by one of GSK’s own legal entities, named exactly as below. Names two employers both claim are left out. How we match

GLEIF register · source

SMITHKLINE BEECHAM PHARMA GMBH & CO. KG · GLAXO WELLCOME SA · GLAXOSMITHKLINE BIOLOGICALS · GLAXOSMITHKLINE BIOLOGICALS GYÓGYSZERGYÁRTÓ ÉS FORGALMAZÓ KORLÁTOLT FELELŐSSÉGŰ TÁRSASÁG · GLAXOSMITHKLINE BIOLOGICALS KFT. · GLAXO WELLCOME PRODUCTION · GSK VACCINES GMBH · CORIXA CORPORATION · GLAXO OPERATIONS UK LIMITED · GLAXOSMITHKLINE VACCINES S.R.L. · GSK VACCINES SRL · GLAXOSMITHKLINE MANUFACTURING S.P.A. · STIEFEL LABORATORIES LEGACY (IRELAND) LIMITED · 14245563 CANADA INC. · GLAXOSMITHKLINE LIMITED · 葛蘭素史克有限公司 · ID BIOMEDICAL CORPORATION OF QUEBEC · CORPORATION ID BIOMÉDICAL DU QUÉBEC · جي إس كيه لايف ساينسز م م ح · BELLUS HEALTH INC. · BELLUS SANTÉ INC. · GLAXO WELLCOME UK LIMITED · VIIV HEALTHCARE LIMITED · VIIV HEALTHCARE UK (NO.3) LIMITED · and 39 more in the register

Wikidata · source

GlaxoSmithKline (Spain) · GlaxoSmithKline (Germany) · GlaxoSmithKline (Italy) · GlaxoSmithKline (Belgium) · GlaxoSmithKline (Croatia) · GlaxoSmithKline (Ireland) · GlaxoSmithKline (United States) · GlaxoSmithKline (Canada) · GlaxoSmithKline (Australia) · GlaxoSmithKline (Poland) · GlaxoSmithKline (Sri Lanka) · Stiefel Laboratories · GlaxoSmithKline (Japan) · GlaxoSmithKline Turkey

What happened

Every event on the record, newest first. Each has its own page; open a row’s reports to see every source. How we decide

  1. 14th Oct
    GSK to cut 1,217 jobs

    Cuts announcedBelgiumOne major outlet so far

    GSK announced potential cuts of up to 1,217 jobs in Belgium as part of a three-year restructuring plan to save £1.9 billion.

    All 9 reports
    1. 14th Oct

      Reuters Major outlet

      GSK announced plans to cut up to 1,217 jobs in Belgium as part of a three-year restructuring plan.

    2. 14th Oct

      finance.yahoo.com Trade press

      GSK plans up to 1,217 job cuts in Belgium.

    3. 14th Oct

      finance.yahoo.com Trade press

      GSK plans up to 1,217 job cuts in Belgium.

    4. 14th Oct

      Fierce Biotech Trade press

      GSK announced up to 1,217 job losses in Belgium as part of global cost-saving plans.

    5. 14th Oct

      Fierce Biotech Trade press

      GSK announced layoffs of over 1,200 roles in Belgium as part of its cost-saving program.

    6. 15th Oct

      hr.economictimes.indiatimes.com Trade press

      GSK announced up to 1,217 job cuts in Belgium.

    7. 18th Oct

      Reuters Major outlet

      GSK announced potential cuts of up to 1,217 jobs in Belgium as part of a three-year restructuring plan to save £1.9 billion.

    8. 18th Oct

      finance.yahoo.com Trade press

      GSK is planning up to 1,217 job cuts in Belgium.

    9. 28th Oct

      pharma.economictimes.indiatimes.com Trade press

      GSK announced plans to cut up to 1,217 jobs in Belgium as part of a three-year restructuring plan.

    Its own page, with the facts →

    1,217jobs cut
  2. 11th Sep
    GSK to cut 641 jobs

    Cuts announcedGermanyOne major outlet so far

    GSK announced closure of its vaccine factory in Germany, putting 641 jobs at risk.

    All 5 reports
    1. 11th Sep

      Reuters Major outlet

      GSK announced closure of its vaccine factory in Germany, putting 641 jobs at risk.

    2. 11th Sep

      finance.yahoo.com Trade press

      GSK announced closure of its vaccine factory in Germany, putting 641 jobs at risk.

    3. 14th Sep

      Fierce Pharma Trade press

      GSK announced closure of its German flu vaccine manufacturing site, described as a difficult decision.

    4. 15th Sep

      finance.yahoo.com Trade press

      GSK plans to close its vaccine manufacturing facility in Dresden, Germany, by summer 2027, putting 641 jobs at risk. The company is consolidating flu vaccine production to its Canada site.

    5. 15th Sep

      finance.yahoo.com Trade press

      GSK announced 641 job cuts in vaccine manufacturing as part of a restructuring initiative.

    Its own page, with the facts →

    641jobs, not yet confirmed
Earlier on the record (4 events, up to a year)
  1. 19th Aug
    GSK announces job cuts

    Cuts announcedStevenage, WareOne major outlet so far

    GSK announced job cuts as part of a £1.9bn cost-cutting programme to fund a £400m UK life sciences investment, including a new Cambridge R&D centre.

    The source: The Guardian
    1. 19th Aug

      The Guardian Major outlet

      GSK announced job cuts as part of a £1.9bn cost-cutting programme to fund a £400m UK life sciences investment, including a new Cambridge R&D centre. The company will close its Stevenage R&D site by 2029 and move over 1,000 scientists to Cambridge.

    Its own page, with the facts →

    No figure
  2. 28th Jul
    GSK books a restructuring charge

    Restructuring chargeOne major outlet so far

    GSK announced a $2.5 billion restructuring programme to accelerate new drug development and raise margin outlook.

    All 2 reports
    1. 28th Jul

      Reuters Major outlet

      GSK announced a $2.5 billion restructuring programme to accelerate new drug development and raise margin outlook.

    2. 28th Jul

      Business Journals Trade press

      GSK unveiled a $2.5B cost-cutting plan in response to anticipated patent cliff challenges.

    Its own page, with the facts →

    No figure
  3. 28th Jul
    GSK reorganises

    ReorganisationUKOne major outlet so far

    GSK announced closure of its historic Stevenage research site with relocation of research centre to Cambridge.

    All 2 reports
    1. 28th Jul

      Financial Times Major outlet

      GSK announced closure of its historic Stevenage research site with relocation of research centre to Cambridge.

    2. 28th Jul

      City A.M. Trade press

      GSK announced sweeping job cuts to fund a £400m Cambridge campus investment.

    Its own page, with the facts →

    No figure
  4. 9th Jan
    GSK to cut 400 jobs

    Cuts announcedWavre, RixensartOne major outlet so far

    GSK cut 400 jobs in Belgium during 2025.

    The source: VRT
    1. 9th Jan

      VRT Major outlet

      GSK cut 400 jobs in Belgium during 2025.

    Its own page, with the facts →

    400jobs, not yet confirmed

Before this year: the formal record

Official documents only (US WARN notices and SEC filings) filed for GSK since 2025. They are shown as filed, one row per document: a round notified at several sites appears once per site. They never change the label, which reads the last 90 days.

Formal documents by year
YearDocumentsJobs they state
20252158
Every document (2)
  1. 29th Sep 2025 WARN notice (CA) Official GSK filed a WARN Act notice for 8 employees affected at a California location, effective 2025-09-29.
  2. 16th Jul 2025 WARN notice (MA) Official GSK filed a WARN notice for 150 employees at its Cambridge, MA facility, effective October 4, 2025.

The signs before the cuts

14th October 2026: cuts announced: 1,217 jobs. In the six months before, the record showed:

  1. 78 days beforeRestructuring charge28th July 2026 · Reuters

11th September 2026: cuts announced. In the six months before, the record showed:

  1. 45 days beforeRestructuring charge28th July 2026 · Reuters

Why, and how

14th October 2026 · Cuts announced · 1,217 jobs

Why, as stated
Cutting costsRestructuring or new strategy

“three-year plan to save £1.9 billion”

11th September 2026 · Cuts announced

Why, as stated
Closing sites or unitsRestructuring or new strategy
How
Sites closing

“GSK reviewed its Dresden and Ste-Foy, Canada, flu vaccine sites and chose to consolidate production in Canada, which it says can meet anticipated demand more sustainably and competitively.”

19th August 2026 · Cuts announced

Why, as stated
Cutting costsRestructuring or new strategy
How
Sites closingRedeploying staff
When
By the end of 2029
Where
Stevenage · Ware · Cambridge

“sweeping job cuts as part of a £1.9bn cost-cutting programme to pay for a £400m investment in UK life sciences”

Only what the sources say. If no report gives a reason, we don’t suggest one.

Named in its cuts
Factory and productionResearch and development
Hiring or moving people into
Research and development
Countries named
BelgiumGermanyUK

In context

How the label has changed · 26 weeks

21st NovCutting → Signs · Reported, not yet confirmed: one major outlet
12th SepSigns → Cutting · Confirmed: 2 major news outlets report job cuts
1st AugQuiet → Signs · Not yet cuts: buyouts offered or a restructuring charge booked; no job cuts confirmed
11th JulSigns → Quiet · Nothing qualifying in the last 180 days

Against its workforce

1 in 56of its staff (1.8%): 1,217 job cuts announced in 12 months, against a workforce of about 68,000.Each square is 1% of GSK’s staff

Share of its sector’s cuts

44%

of the 2,749 job cuts announced in 12 months by the employers we rate in pharma & healthcare.

Peers in pharma & healthcare

  1. GSK1.8%
  2. AstraZeneca0.7%
  3. Novartis0.4%
  4. Novo Nordisk0.4%
  5. Johnson & Johnson0.2%

Job cuts in 12 months as a share of each employer’s workforce.

Use this record RSS · JSON · Embed · Ask an AI ·
Put GSK’s label on your site

Two lines show the label and the latest cut, and update themselves. No cookies. About the badge

<div data-talentrisk="gsk"></div>
<script async src="https://talentrisk.com/embed.js"></script>

Right of reply

GSK can reply or correct this record at any time.

Correct the record →

This label is our opinion, reached by applying one published rule to the sources listed.